AstraZeneca News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

17.10.17	AstraZeneca: FDA Accepts SBLA File For Imfinzi, Gets Priority Review (RTTNews)
16.10.17	Experienced Healthcare Executive Mike Heenan Joins StrategyCorp (PR Newswire)
10.10.17	CLVS Seeks New Use For Rubraca, TNDM Effects Reverse Stock Split, MDXG On Watch (RTTNews)
09.10.17	AstraZeneca: FDA Grants Breakthrough Therapy Designation For Tagrisso (RTTNews)
25.09.17	NewLink, AstraZeneca Sign Immuno-oncology Clinical Collaboration Deal (RTTNews)
13.09.17	Breakfast Technical Briefing on Drug Makers Stocks -- AbbVie, AstraZeneca, Bristol Myers Squibb, and Johnson & Johnson (PR Newswire)
11.09.17	AstraZeneca: Superior Progression-free Survival For Imfinzi In Pacific Trial (RTTNews)
11.09.17	New Hope For AZN's Old Drug, More About BMY's Opdivo, IMDZ On Watch (RTTNews)
09.09.17	AstraZeneca Reports Positive Lung Cancer Drug Data From Phase III FLAURA Trial (RTTNews)
07.09.17	AstraZeneca Posting Notable Gain On Positive Drug Trial Results (RTTNews)
07.09.17	AstraZeneca Announces Results From PATHWAY Phase IIb Trial Of Tezepelumab (RTTNews)
07.09.17	AstraZeneca: Phase III Amplify Trial For Duaklir Meets Primary Endpoints (RTTNews)
06.09.17	Tezepelumab Significantly Reduced Asthma Exacerbations For A Broad Population Of Patients With Severe Uncontrolled Asthma (PR Newswire)
28.08.17	AstraZeneca's FASLODEX Receives US FDA Approval (RTTNews)
18.08.17	FDA Nod For PFE, New Use For AZN's Ovarian Cancer Drug, ELGX's LEOPARD Hits Goal (RTTNews)
18.08.17	LYNPARZA Gets Additional And Broad Approval In U.S. For Ovarian Cancer (RTTNews)
17.08.17	Race For A New Alzheimer's Drug (RTTNews)
10.08.17	Technical Snapshots for These Drug Makers Stocks -- AbbVie, AstraZeneca, Bristol Myers Squibb, and Johnson & Johnson (PR Newswire)
03.08.17	Recent FDA Decisions and Clinical Trial Developments Influencing Current Biotech Run (PR Newswire)
03.08.17	Recent FDA Decisions and Clinical Trial Developments Influencing Current Biotech Run (PR Newswire)
02.08.17	AZN :FDA Accepts Regulatory Submission For Acalabrutinib, Grants Priority Review (RTTNews)
01.08.17	AstraZeneca: Acalabrutinib Gets Breakthrough Therapy Designation From FDA (RTTNews)
31.07.17	AstraZeneca: FDA Grants Breakthrough Therapy Designation For Imfinzi (RTTNews)
28.07.17	AGRX At FDA Altar Again, AZN Falls As MYSTIC Fails, VBIV Delivers A Good Shot (RTTNews)
28.07.17	Gainers & Losers Of July 27: CAPR, ANIK, MMSI, AZN, TTPH, AGEN... (RTTNews)
27.07.17	Valeant Announces U.S. Launch of SILIQ™ (brodalumab) Injection (PR Newswire)
27.07.17	AstraZeneca Posts Q2 Profit; Backs 2017 Outlook (RTTNews)
13.07.17	AstraZeneca Stock Dips After Report Says CEO Pascal Soriot Plans To Move To Teva (RTTNews)
05.07.17	Breakfast Technical Briefing on Drug Makers Stocks -- Bristol Myers Squibb, Eli Lilly, AstraZeneca, and Sanofi (PR Newswire)
20.06.17	GSK Confirms Start Date For Luke Miels As President, Global Pharma (RTTNews)
12.06.17	Pieris - AstraZeneca Collaboration Receives U.S. Approval (RTTNews)
12.06.17	AstraZeneca Presents New Data On Farxiga (RTTNews)
07.06.17	Astrazeneca To Divest Rights To Migraine Drug Zomig To Grünenthal (RTTNews)
06.06.17	AstraZeneca: Tagrisso Data Shows Activity In EGFR Mutation-positive NSCLC (RTTNews)
04.06.17	AZN' Lynparza Reduces Risk Of Disease Worsening Or Death By 42% In Breast Cancer (RTTNews)
02.06.17	Orexo Stock Up On $2.5 Mln Milestone Payment From AstraZeneca (RTTNews)
02.06.17	Company Spotlight: Albireo Pharma (RTTNews)
01.06.17	Drug Makers Stocks on Investors' Radar -- AstraZeneca, Bristol-Myers Squibb, Eli Lilly, and Sanofi (PR Newswire)
26.05.17	AstraZeneca Recalls One Lot Of BRILINTA 90mg Professional Sample Bottles (RTTNews)
23.05.17	AstraZeneca: Bydureon EXSCEL Trial Meets Primary Safety Goal In Type-2 Diabetes (RTTNews)
22.05.17	AstraZeneca, Recordati Enter Deal For Seloken; AstraZeneca To Receive $300 Mln (RTTNews)
14.05.17	AZN's PACIFIC Proves To Have Depth, ARDX Abuzz, No Flashy Data From ALLSTAR (RTTNews)
12.05.17	AstraZeneca Posting Strong Gain On Positive Drug Trial Results (RTTNews)
12.05.17	AstraZeneca, MedImmune Report Positive Results For Imfinzi Trial In NSCLC (RTTNews)
11.05.17	FDA Nod For MRK's Keytruda, SGMO Soars On Gene Therapy Deal, OMER Catches Eyes (RTTNews)
10.05.17	AstraZeneca : Tralokinumab Fails To Meet Primary Endpoint Of Reduction In AAER (RTTNews)
02.05.17	AstraZeneca Announces Accelerated FDA Approval Of Imfinzi - Quick Facts (RTTNews)
02.05.17	AZN Gets FDA Nod, CORT Boosts Outlook Yet Again, SNSS Withdraws Vosaroxin MAA (RTTNews)
27.04.17	AstraZeneca Q1 Profit, Revenues Down; Backs Weak Outlook For FY17; Stock Dips (RTTNews)
27.04.17	AstraZeneca Q1 Net Profit Down, Core EPS Up; Confirms FY17 Forecast (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

24.12.24		Optimismus in New York: NASDAQ 100 verbucht zum Ende des Dienstagshandels Zuschläge
24.12.24		Börse New York in Grün: NASDAQ 100 steigt nachmittags
24.12.24		AstraZeneca-Aktie dennoch fester: AstraZeneca und Daiichi Sankyo rudern bei EU-Zulassungsantrag für Lungenkrebsmittel zurück
23.12.24		AstraZeneca-Aktie höher: EU-Zulassung für Tagrisso gegen weitere Lungenkrebsform
18.12.24		Schwacher Handel in New York: NASDAQ 100 am Mittwochnachmittag schwächer
04.12.24		Zuversicht in New York: NASDAQ 100 zum Handelsstart freundlich
03.12.24		Starker Wochentag in New York: NASDAQ 100 steigt zum Handelsende
03.12.24		Starker Wochentag in New York: NASDAQ 100 am Nachmittag mit Kursplus

24.12.24

Optimismus in New York: NASDAQ 100 verbucht zum Ende des Dienstagshandels Zuschläge

24.12.24

Börse New York in Grün: NASDAQ 100 steigt nachmittags

24.12.24

AstraZeneca-Aktie dennoch fester: AstraZeneca und Daiichi Sankyo rudern bei EU-Zulassungsantrag für Lungenkrebsmittel zurück

23.12.24

AstraZeneca-Aktie höher: EU-Zulassung für Tagrisso gegen weitere Lungenkrebsform

18.12.24

Schwacher Handel in New York: NASDAQ 100 am Mittwochnachmittag schwächer

04.12.24

Zuversicht in New York: NASDAQ 100 zum Handelsstart freundlich

03.12.24

Starker Wochentag in New York: NASDAQ 100 steigt zum Handelsende

03.12.24

Starker Wochentag in New York: NASDAQ 100 am Nachmittag mit Kursplus

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu AstraZeneca PLC (spons. ADRs)

Aktien Top/Flop

AstraZeneca Peer Group Nachrichten

Meistgelesene Nachrichten